Back to results
US 2020/0299234 A1Published application
Compositions for treating neurodegenerative diseases
AssigneeCognition Therapeutics, Inc.
InventorsGilbert M. RISHTON, Gary C. LOOK, Susan M. CATALANO
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to novel compounds, pharmaceutical compositions containing the compounds and methods of using the compounds and pharmaceutical compositions for treating neurodegenerative diseases, including Alzheimer's disease and cognitive decline. Methods for inhibiting synapse number decline or membrane trafficking abnormalities associated with exposure of a neuronal cell to Abeta species are also disclosed.
Claims21
A compound of Formula I or pharmaceutically acceptable salt thereof:
- wherein:
- each of Ra, Rb, Rc, Rd and Re is independently selected from the group consisting of, H, hydroxyl, halo, alkyl, alkoxy, CF3, SO2CH3, and morpholino;
- R1 is selected from the group consisting of hydrogen, alkyl, phenyl, or —CH═C(CH3)2;
- and
- R2 is an optionally substituted cyclic amino group.
2 more elements
A compound selected from the group consisting of
- or a pharmaceutically acceptable sat thereof.
-27. (canceled)
Dependencies are inferred from the claim text.